| MDL | - |
|---|---|
| Molecular Weight | 357.46 |
| Molecular Formula | C21H28FN3O |
| SMILES | CC1=NC(OCCCCCN2CCCCC2)=CC(C3=CC=C(F)C=C3)=N1 |
Enecadin is a neuroprotective agent extracted from patent US 8623823 B2.
Enecadin is a neuroprotective agent which can be useful for the treatment of stroke or other cerebrovascular accident [1] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
| NCT Number | Sponsor | Condition | Start Date | Phase |
|---|---|---|---|---|
| NCT00331721 | PAION Deutschland GmbH |
Stroke
|
May 2006 | Phase 2 |
Solid
Room temperature in continental US; may vary elsewhere.
| Powder | -20°C | 3 years |
|---|---|---|
| 4°C | 2 years | |
| In solvent | -80°C | 6 months |
| -20°C | 1 month |
DMSO : ≥ 50 mg/mL ( 139.88 mM )
* "≥" means soluble, but saturation unknown.
| Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 2.7975 mL | 13.9876 mL | 27.9752 mL |
| 5 mM | 0.5595 mL | 2.7975 mL | 5.5950 mL |
| 10 mM | 0.2798 mL | 1.3988 mL | 2.7975 mL |
Add each solvent one by one: 10% DMSO >> 90% corn oil
Solubility: ≥ 2.08 mg/mL (5.82 mM); Clear solution